Literature DB >> 9264092

Effects of brief caffeinated-beverage deprivation on mood, symptoms, and psychomotor performance.

J D Lane1.   

Abstract

The effects of short-term deprivation of caffeinated beverages on mood, withdrawal symptoms, and psychomotor performance were studied in habitual coffee drinkers. Twenty-four male and female coffee drinkers were tested at midday (1130-1330 h) under two conditions. On one day they consumed caffeinated beverages ad lib prior to testing, and on the other they remained caffeine abstinent. The order of treatments was counterbalanced. Mood and withdrawal symptom reports were collected by questionnaires. Psychomotor performance was tested with a computerized test battery. Caffeinated-beverage deprivation was associated with decreased vigor and increased fatigue and with symptoms including headache. No changes in psychomotor performance were observed. Even short periods of caffeinated-beverage deprivation, equivalent in length to missing regular morning coffee, can produce noticeable unpleasant caffeine-withdrawal symptoms by the middle of the day. These symptoms may be a common side effect of habitual caffeinated beverage consumption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264092     DOI: 10.1016/s0091-3057(97)00007-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  Central and peripheral effects of sustained caffeine use: tolerance is incomplete.

Authors:  Joanne Watson; Ian Deary; David Kerr
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

Review 2.  A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.

Authors:  Laura M Juliano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-21       Impact factor: 4.530

3.  Caffeine reinforces flavour preference in caffeine-dependent, but not long-term withdrawn, caffeine consumers.

Authors:  Elizabeth M Tinley; Martin R Yeomans; Paula J Durlach
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

4.  Fourteen well-described caffeine withdrawal symptoms factor into three clusters.

Authors:  Stephen Ozsungur; Darren Brenner; Ahmed El-Sohemy
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

5.  Expectations and placebo responses to caffeine-associated stimuli.

Authors:  Magne Arve Flaten; Ole Aasli; Terry D Blumenthal
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

6.  Use of therapeutic caffeine in acute care postoperative and critical care settings: a scoping review.

Authors:  M Bright; V Raman; K B Laupland
Journal:  BMC Anesthesiol       Date:  2021-03-31       Impact factor: 2.217

Review 7.  Caffeine and stress: implications for risk, assessment, and management of hypertension.

Authors:  T R Hartley; W R Lovallo; T L Whitsett; B H Sung; M F Wilson
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Nov-Dec       Impact factor: 3.738

8.  Caffeine promotes global spatial processing in habitual and non-habitual caffeine consumers.

Authors:  Grace E Giles; Caroline R Mahoney; Tad T Brunyé; Holly A Taylor; Robin B Kanarek
Journal:  Front Hum Neurosci       Date:  2013-10-17       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.